Literature DB >> 1361288

The genetic risk for alopecia areata in first degree relatives of severely affected patients. An estimate.

P van der Steen1, H Traupe, R Happle, J Boezeman, R Sträter, H Hamm.   

Abstract

Substantial evidence indicates that genetic factors may have a role in the etiology of alopecia areata (AA). Most studies, however, provide only general information on the familial incidence but fail to specify family relationships. We therefore obtained information on the incidence of AA in first degree relatives of 348 severely affected patients. In 7% one of the parents was affected. Among the siblings of the patients 3% had developed AA, while AA was present in 2% of the children. Taking into account the age of the children, their lifetime risk was calculated to approach 6%. However, a severe type of AA is to be expected only in about 2% of the children. The degree of involvement observed in the patients did not influence the frequency and type of AA present in their first degree relatives.

Entities:  

Mesh:

Year:  1992        PMID: 1361288     DOI: 101080/000155572373375

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  18 in total

1.  Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata.

Authors:  Amalia Martinez-Mir; Abraham Zlotogorski; Derek Gordon; Lynn Petukhova; Jianhong Mo; T Conrad Gilliam; Douglas Londono; Chad Haynes; Jurg Ott; Maria Hordinsky; Krassimira Nanova; David Norris; Vera Price; Madeleine Duvic; Angela M Christiano
Journal:  Am J Hum Genet       Date:  2007-01-05       Impact factor: 11.025

Review 2.  Alopecia Areata: a Comprehensive Review of Pathogenesis and Management.

Authors:  Ralph M Trüeb; Maria Fernanda Reis Gavazzoni Dias
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 3.  [Genetically induced hair diseases].

Authors:  T Wiederholt; P Poblete-Gutiérrez; J Frank
Journal:  Hautarzt       Date:  2003-07-04       Impact factor: 0.751

4.  Genome-wide association study in alopecia areata implicates both innate and adaptive immunity.

Authors:  Lynn Petukhova; Madeleine Duvic; Maria Hordinsky; David Norris; Vera Price; Yutaka Shimomura; Hyunmi Kim; Pallavi Singh; Annette Lee; Wei V Chen; Katja C Meyer; Ralf Paus; Colin A B Jahoda; Christopher I Amos; Peter K Gregersen; Angela M Christiano
Journal:  Nature       Date:  2010-07-01       Impact factor: 49.962

5.  Heat treatment increases the incidence of alopecia areata in the C3H/HeJ mouse model.

Authors:  Tongyu Cao Wikramanayake; Elizabeth Alvarez-Connelly; Jessica Simon; Lucia M Mauro; Javier Guzman; George Elgart; Lawrence A Schachner; Juan Chen; Lisa R Plano; Joaquin J Jimenez
Journal:  Cell Stress Chaperones       Date:  2010-06-27       Impact factor: 3.667

Review 6.  Alopecia areata.

Authors:  C Herbert Pratt; Lloyd E King; Andrew G Messenger; Angela M Christiano; John P Sundberg
Journal:  Nat Rev Dis Primers       Date:  2017-03-16       Impact factor: 52.329

7.  Association analysis of the HLA-C gene in Japanese alopecia areata.

Authors:  Yuko Haida; Shigaku Ikeda; Atsushi Takagi; Etsuko Komiyama; Tomotaka Mabuchi; Akira Ozawa; Jerzy K Kulski; Hidetoshi Inoko; Akira Oka
Journal:  Immunogenetics       Date:  2013-04-16       Impact factor: 2.846

Review 8.  Genetic basis of alopecia areata: a roadmap for translational research.

Authors:  Ali Jabbari; Lynn Petukhova; Rita M Cabral; Raphael Clynes; Angela M Christiano
Journal:  Dermatol Clin       Date:  2012-10-23       Impact factor: 3.478

Review 9.  What causes alopecia areata?

Authors:  K J McElwee; A Gilhar; D J Tobin; Y Ramot; J P Sundberg; M Nakamura; M Bertolini; S Inui; Y Tokura; L E King; B Duque-Estrada; A Tosti; A Keren; S Itami; Y Shoenfeld; A Zlotogorski; R Paus
Journal:  Exp Dermatol       Date:  2013-09       Impact factor: 3.960

10.  Alopecia universalis in a patient with rheumatoid arthritis developed during treatment with adalimumab.

Authors:  P Ostojic; S Pavlov-Dolijanovic
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.